The study, conducted by a team of Johnson and Johnson researchers, looked at pre-existing studies performed between December 2019 and August 2020 for Covid and between January 2020 and June 2021 for Long Covid, which showed the effects of COVID-19 on 1.3 Evaluated. Millions of people.
Published in Current Medical Research and Opinion, this study is the first to assess specific health conditions that occur as a result of coronavirus-related illnesses by gender.
According to the study’s authors, “Knowledge of the basic sex differences based on the clinical manifestations of Covid-19, disease progression and health outcomes is crucial for the identification of effective therapies. . “
“Women mount more rapid and stronger immune responses, which can protect them from early infection.
“However, this same distinction may put women at risk for chronic autoimmune-related diseases,” they added.